 |
PDBsum entry 3kba
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transcription
|
PDB id
|
|
|
|
3kba
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Bioorg Med Chem Lett
20:371-374
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Improving the developability profile of pyrrolidine progesterone receptor partial agonists.
|
|
L.S.Kallander,
D.G.Washburn,
T.H.Hoang,
J.S.Frazee,
P.Stoy,
L.Johnson,
Q.Lu,
M.Hammond,
L.S.Barton,
J.R.Patterson,
L.M.Azzarano,
R.Nagilla,
K.P.Madauss,
S.P.Williams,
E.L.Stewart,
C.Duraiswami,
E.T.Grygielko,
X.Xu,
N.J.Laping,
J.D.Bray,
S.K.Thompson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The previously reported pyrrolidine class of progesterone receptor partial
agonists demonstrated excellent potency but suffered from serious liabilities
including hERG blockade and high volume of distribution in the rat. The basic
pyrrolidine amine was intentionally converted to a sulfonamide, carbamate, or
amide to address these liabilities. The evaluation of the degree of partial
agonism for these non-basic pyrrolidine derivatives and demonstration of their
efficacy in an in vivo model of endometriosis is disclosed herein.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |